Taken together, our findings indicate that targeting the Akt/AS160/Rab14 axis could constitute a novel strategy to limit chlamydial infections, mainly for those caused by antibiotic-resistant bacteria. The gene discussed is RAB14; the disease is chlamydia trachomatis infectious disease.